The Scheele Award

In honour of the world-renowned Swedish chemist and pharmacist Carl Wilhelm Scheele, the Swedish Pharmaceutical Society has since 1961 bestowed the Scheele Award on prominent scientists in the field of drug research or related disciplines. By tradition the award ceremony is accompanied by a symposium carrying the signature of the prize-winner.

Criteria

1. Discovery of New Drug Candidates
   
   • The nominee has discovered a novel drug candidate or made a significant contribution to the advancement of a molecule to clinical use.
2. Mechanism of Action
   
   • The nominee has opened up a new research field and demonstrated an innovative approach to targeting disease, or identified target molecules or signaling pathways of clear relevance to patients.
   • Purely basic research on disease mechanisms is not sufficient; demonstrated relevance to patients is required. While a finalized drug is not necessary, the discovery should be considered to have high translational potential.
3. Tools, Methods, and Technologies
   
   • The nominee has developed methods, tools, or technologies of substantial importance to drug research and development. These contributions do not need to be linked to a specific drug.
   • Examples include synthetic methodologies, analytical techniques, gene therapy approaches, cell-based systems, development of in vivo or in vitro models, or computational/simulation methods used to identify and evaluate drug candidates.
4. Formulation and Drug Delivery
   
   • The nominee has made significant contributions to formulation or drug delivery that have either advanced the field substantially or played a decisive role in enabling the development of a specific therapeutic.